Conatus Pharmaceuticals' Series A - II Round

Conatus Pharmaceuticals raised a round of funding on May 22, 2007.

Conatus Pharmaceuticals, a privately-held biotechnology company, is engaged in the development of human therapeutics to treat liver disease. Conatus is developing its lead compound, emricasan, for the…

Articles about Conatus Pharmaceuticals' Series A - II Round: